Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenip Plc Regulatory News (GNIP)

Share Price Information for Genip Plc (GNIP)

Share Price is delayed by 15 minutes
Get Live Data
4.65    0.00 (0.00%)
Bid:
4.50
Ask:
4.80
Spread: 0.30 (6.667%)
Market Cap: £1.19m
GNIP Live PriceLast checked at - London Stock Exchange

Intraday Genip Plc Share Chart

New Report Orders From Repeat Clients

21 Nov 2025 07:00

RNS Number : 4234I
GenIP PLC
21 November 2025
 

 

 

 

21 November 2025 

 

GenIP Plc

("GenIP" or the "Company")

 

New Report Orders From Repeat Clients

 

 

GenIP Plc, an AI-powered innovation intelligence and technology commercialisation company, is pleased to announce it has received a total of 57 new report orders from repeat clients, including two leading U.S. research universities and a returning UK institution. These orders reflect continued demand for GenIP's AI-enabled analytical products and the strengthening of long-term client relationships.

 

The Company has secured 50 new Invention Evaluator report orders from two major U.S universities, both recognised for their substantial innovation output and commercialisation performance: One institution has been repeatedly ranked in the National Academy of Inventors "Top 100 U.S. Universities Granted Utility Patents", demonstrating sustained leadership in translating research into protected intellectual property. The other operates one of the most active university innovation hubs in the United States, publicly tracking thousands of invention disclosures, patent filings, and spinoff ventures annually through its dedicated commercialisation centre.

 

In addition, a UK university first onboarded in June 2025 has placed a further 7 report orders, demonstrating continued engagement and the recurrent nature of GenIP's services.

 

GenIP believes these repeat orders validate GenIP's value proposition and demonstrate the effectiveness of our AI-powered analytical assessments in supporting technology transfer decisions.

 

Melissa Cruz, CEO of GenIP, commented:

 

"The continued return of leading institutions reinforces the market's need for faster, more reliable decision-support in technology commercialization. We are also seeing a rise in inbound referrals from universities that have reported meaningful improvements in their licensing workflows after adopting our evaluations. This combination of repeat business and organic referrals gives us strong confidence in our growth trajectory as we expand our AI-powered product suite and support more clients globally."

 

 

For further information regarding GenIP, please visit www.genip.ai, or contact:

 

GenIP Plc

Melissa Cruz, CEO 

Via Redchurch Communications

Redchurch Communications (Financial PR)

John Casey

 

 

genip@weareredchurch.com

 

About Reach announcements

 

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

Notes to Editors

 

About GenIP

 

GenIP is a next-generation consultancy at the intersection of generative AI and innovation strategy. We empower corporates, venture funds, and research institutions to evaluate, commercialise, and scale breakthrough technologies. By combining proprietary GenAI algorithms with expert human analysis, GenIP delivers decision-grade insights and talent solutions that accelerate innovation outcomes.

 

Service Offerings

 

GenIP operates through two synergistic service lines:

 

Service

Description

Value Proposition

Invention Intelligence Product Suite

AI-powered market intelligence reports assessing the commercial potential of emerging technologies

Enables faster, evidence-based decisions on R&D prioritisation, investment, and IP strategy

Talent and Executive Search Services

Executive search platform using machine learning and NLP to match innovation-driven organisations with commercialisation-ready leadership

De-risks scaling by aligning technical vision with proven executive capability

 

Together, these services form a unified GenAI-enabled platform for innovation triage and execution.

 

Vision & Strategy

 

GenIP aims to become the global leader in generative AI analytics for innovation commercialisation. Our strategy is anchored in three growth pillars:

 

Organic ExpansionScale Invention Evaluator and Recruitment Services through targeted outreach to corporates, VCs, and research institutions, supported by strategic marketing and digital engagement.

Service DeepeningEnhance functionality and margin by expanding GenAI capabilities within both service lines-unlocking new use cases and customer segments.

Strategic AcquisitionsPursue bolt-on acquisitions of complementary GenAI services with validated market traction to broaden our offering and accelerate growth.

 

-ENDS-

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPKKBNPBDDCDB
Date   Source Headline
24th Jun 20265:18 pmRNSResult of AGM
24th Jun 20267:00 amRNS-RGenIP Innovation Roundtable
29th May 20265:52 pmRNSTotal Voting Rights
27th May 20267:00 amRNSAudited Final Results FY25 and Notice of AGM
21st May 20267:00 amRNSNew Orders
5th May 202611:35 amRNSTR-1: Notification of major holdings
1st May 20267:00 amRNSShare Placing to raise £350,000 and TVR
28th Apr 20267:00 amRNSStrategic Resale Alliance with Cardinal IP
31st Mar 20267:00 amRNS-RCommercial Update
10th Feb 20267:00 amRNS-RSales and Product Update
15th Jan 20267:00 amRNSCorporate Update
4th Dec 20257:00 amRNSOperational Update, Placing and TVR
21st Nov 20257:00 amRNS-RNew Report Orders From Repeat Clients
13th Nov 20257:00 amRNSTrading Statement
15th Oct 20257:00 amRNS-RTechnology Park Alliance
10th Oct 20257:00 amRNSNew Product Launch – Invention Validator
6th Oct 20257:00 amRNSReplacement RNS: Half-year Report
30th Sep 20257:02 amRNSCommercial Strategy Update & New Products
30th Sep 20257:00 amRNSHalf-year Report
24th Sep 20257:00 amRNS-RStrategic Partnership
15th Sep 20257:00 amRNS-RStrategic Partnership
25th Jul 20257:00 amRNSTrading Statement
1st Jul 20257:00 amRNS-RGenIP Secures First UK Academic Clients
26th Jun 20255:07 pmRNSResult of AGM
10th Jun 20257:00 amRNSContract Win
4th Jun 20257:00 amRNSAudited Results for Period Ended 31 December 2024
2nd Jun 20256:27 pmRNSNotice of AGM
29th May 20257:00 amRNS-RBusiness Update
7th May 20257:00 amRNS-RGenIP to attend 2025 AUTM Canadian Region Meeting
1st May 20257:00 amRNS-RNew Product Launch
31st Mar 20255:34 pmRNSUnaudited Results to 31 December 2024
26th Mar 20257:00 amRNS-RContract Win
20th Mar 20257:00 amRNS$0.35m Contract Win
13th Mar 20257:00 amRNSCorporate Update & 2025 Outlook
11th Feb 20257:00 amRNS-RGenIP to Sponsor the AUTM 2025 Annual Meeting
3rd Dec 20245:29 pmRNSTR-1: Notification of major holdings
20th Nov 20247:00 amRNSCorporate Update
8th Oct 20247:00 amRNSCorporate Update
2nd Oct 20247:00 amRNSAdmission to Trading on AIM-First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.